Dosidal · Switzerland

Inflectra, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:65367 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 65367
atc: L04AB02
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2015-10-09
term: zugelassen
valid_until: 2027-04-30
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: L04AB02
authorisation_number: 65367
form: PULPA
holder: Pfizer AG
holder_partner_nr: 1001107
it_number: 07.15.0.
name: Inflectra, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
UVMdHtvDGXTVjSXgxu1tr_AdPmKrFjuxH3PNKD8f7ZRXWL9bm7xovT8sZQgC3UwyW4JZcpUAkwmg7n_HHGBFUw
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:65367 · Same medicine in other markets · Dosidal